Participating Staff Sample Clauses

Participating Staff. The Investigator hereby declares that he/she has the required experience for conducting the Trial. The Institution and Investigator shall duly perform the conditions of this Agreement. The Institution shall not be able to replace the Investigator with another Investigator without the prior written consent of Biogen. The Institution shall provide, and shall cause the Investigator to provide, Biogen and its representatives with information regarding the staff participating in the Trial (the Staff). For the avoidance of doubt, the Staff shall throughout the term of this Agreement be under the supervision and control of the Investigator, and Investigator shall without limitation be responsible for ensuring that the Staff act in accordance with the Applicable Laws and Regulations, guidelines issued by the State Institute for Drug Control – LEK-12 and, Biogen’s and its representatives’ reasonable instructions. (b) Xxxxxxxxxx xxxxxxxx. Xxxxxxxxxx xxxxx xxxxxxxxxx, xx má požadované zkušenosti pro provádění Klinického hodnocení. Zdravotnické zařízení a Zkoušející budou tuto smlouvu řádně plnit. Zdravotnické zařízení nesmí Zkoušejícího nahradit jiným Zkoušejícím bez předchozího písemného souhlasu společnosti Biogen. Zdravotnické zařízení bude společnosti Biogen a jejím zástupcům poskytovat (a zajistí, aby tak činil i Zkoušející) informace ohledně pracovníků podílejících se na Klinickém hodnocení (dále jen „Personál“). Aby se předešlo jakýmkoliv pochybnostem, bude Personál po dobu trvání této smlouvy pod dozorem a kontrolou Zkoušejícího a Zkoušející ponese neomezenou odpovědnost za to, že Personál bude jednat v souladu s příslušnými zákony a právními předpisy, pokynu vydaného SÚKL č. LEK-12 a podle pokynů společnosti Biogen či jejích zástupců. The Institution will authorize an employee and member of the Staff appropriately qualified to act as the pharmacist to secure proper handling and subsequent distribution of the Product as requested by the Investigator, and in accordance with Good Pharmacy Practice (Regulation No. 84/2008 Coll.), Applicable Laws and Regulations and the provisions of the Protocol. Zdravotnické zařízení pověří příslušně kvalifikovaného zaměstnance a člena Personálu v pozici farmaceuta k zajištění řádného zacházení a následného výdeje Produktu dle požadavků Zkoušejícího, v souladu se Správnou lékárenskou praxí (vyhláška č. 84/2008 Sb.), Platnými zákony a předpisy a ustanoveními Protokolu.
Sample 1See All (5)
AutoNDA by SimpleDocs
Participating Staff. The Investigator hereby declares that he/she has the required experience for conducting the Trial. The Institution and Investigator shall duly perform the conditions of this Agreement. The Institution shall not be able to replace the Investigator with another Investigator without the prior written consent of Biogen. The Institution shall provide, and shall cause the Investigator to provide, Biogen and its representatives with information regarding the staff participating in the Trial (the Staff). For the avoidance of doubt, the Staff shall throughout the term of this Agreement be under the supervision and control of the Investigator, and Investigator shall without limitation be responsible for ensuring that the Staff act in accordance with the Applicable Laws and Regulations, guidelines issued by the State Institute for Drug Control – LEK-12 and, Biogen’s and its representatives’ reasonable instructions. Zdravotnické zařízení pověří příslušně kvalifikovaného zaměstnance a člena Personálu v pozici farmaceuta k zajištění řádného zacházení a následného výdeje Produktu dle požadavků Zkoušejícího, v souladu se Správnou lékárenskou praxí (vyhláška č. 84/2008 Sb.), Platnými zákony a předpisy a ustanoveními Protokolu. The Institution will authorize an employee and member of the Staff appropriately qualified to act as the pharmacist to secure proper handling and subsequent distribution of the Product as requested by the Investigator, and in accordance with Good Pharmacy Practice (Regulation No. 84/2008 Coll.), Applicable Laws and Regulations and the provisions of the Protocol.
Sample 1
Participating Staff. The Study shall be conducted under the immediate direction of the Investigator. Institution shall ensure that all Study Staff, including Investigator, personally perform their assigned Study tasks, as indicated in the Protocol and in accordance with this Agreement. Investigator shall qualify such personnel and oversee the work of other Study Staff. Investigator may have one or more sub-investigator(s) work on the Study; provided, however, that Investigator is responsible for all work conducted by sub-investigator. Any such sub-investigator shall be subject to all of the terms and conditions of this Agreement, including all obligations of Investigator. No sub-investigator may work on the Study unless he or she is qualified through experience and training to conduct clinical studies and agrees to be involved through completion of the Study. The sub-investigator’s name shall appear in the appropriate space on the FDA Form 1572. Notwithstanding the foregoing, Sponsor may disapprove any proposed sub-investigator within five (5) days of submission of FDA Form 1572. For purposes of this Agreement, “Staff” shall mean all Institution personnel including, but not limited to, faculty, researchers, investigators, sub-investigators, study coordinators and any other person performing services related to the Study on behalf of Institution, or to whom Institution provides access to Study materials or study drug (“Study Drug”). < Institution> CTA
Sample 1
Participating Staff. Biogen shall appoint the Investigator as the medical specialist responsible for the conduct of the Trial on its own responsibility. The Institution hereby declares that the Investigator has undergone the necessary training and has the required experience, skills, knowledge and facilities for conducting the Trial. The Institution shall guarantee that the Trial will be duly performed by the Investigator in accordance with this Agreement. The Institution shall not be able to replace the Investigator with another investigator without the prior written consent of Biogen. The Investigator shall provide Biogen and its representatives with information regarding the other staff participating in the Trial (the Investigator and the other staff collectively referred to as the “Staff”). For the avoidance of doubt, the Staff shall throughout the term of this Agreement be under the supervision and control of the Institution. The Institution acknowledges and agrees that the Investigator enters into a separate agreement with Biogen and the CRO under which he/she will receive direct payment from the CRO for the services performed by the Investigator in connection with the Trial and by the other Staff members. The Institution assures that the performance of this separate agreement between Biogen and the Investigator will not constitute a violation of the Investigator’s duties nor a violation of the other Staff members’ duties. Agreements shall be concluded between Biogen and each respective Staff member, including but not limited to the Investigator, which shall stipulate terms and conditions of remuneration for each Staff member. Members of the Staff shall be solely responsible for due taxation of their income. Zdravotnické zařízení pověří příslušně kvalifikovaného zaměstnance a člena Personálu v pozici farmaceuta k zajištění řádného zacházení a následného výdeje Produktu dle požadavků Zkoušejícího, v souladu se Správnou lékárenskou praxí (vyhláška č. 84/2008 Sb.), Platnými zákony The Institution will authorize an employee and member of the Staff appropriately qualified to act as the pharmacist to secure proper handling and subsequent distribution of the Product as requested by the Investigator, and in accordance with Good Pharmacy Practice (Regulation No. 84/2008 Coll.), Applicable Laws and Regulations and the provisions a předpisy a ustanoveními Protokolu. of the Protocol.
Sample 1
Participating Staff. The Investigator hereby declares that he/she has undergone the necessary training and has the required experience and means for conducting the Trial. The Institution acknowledges that Investigator shall guarantee that this Agreement will be duly. The Institution shall not be able to replace the Investigator with another Investigator without the prior written consent of Biogen. The Institution shall provide, and shall cause the Investigator to provide, Biogen and its representatives with information regarding the staff participating in the Trial (the Staff). For the avoidance of doubt, the Staff shall throughout the term of this Agreement be under the supervision and control of the Institution and the Investigator, and the Institution and Investigator shall without limitation be responsible for ensuring that the Staff act in accordance with the Applicable Laws and Regulations and, Biogen’s and its representatives’ reasonable instructions. Zdravotnické zařízení pověří příslušně kvalifikovaného zaměstnance a člena Personálu v pozici farmaceuta k zajištění řádného zacházení a následného výdeje Produktu dle požadavků Zkoušejícího, v souladu se Správnou lékárenskou praxí (vyhláška č. 84/2008 Sb.), Platnými zákony a předpisy a ustanoveními Protokolu. The Institution will authorize an employee and member of the Staff appropriately qualified to act as the pharmacist to secure proper handling and subsequent distribution of the Product as requested by the Investigator, and in accordance with Good Pharmacy Practice (Regulation No. 84/2008 Coll.), Applicable Laws and Regulations and the provisions of the Protocol.
Sample 1
Participating Staff. The InstitutionFoundation shall choose the Investigator on its own responsibility. The InstitutionFoundation hereby declares that the Investigator has undergone the necessary training and has the required experience and means for conducting the Trial. The InstitutionFoundation shall guarantee that this Agreement will be duly performed by the Investigator chosen on its responsibility. The InstitutionFoundation shall not be able to replace the Investigator with another Investigator without the prior written consent of Biogen. The InstitutionFoundation shall provide, and shall cause the Investigator to provide, Biogen and its representatives with information regarding the staff participating in the Trial (the Staff). For the avoidance of doubt the Staff shall throughout the term of this Agreement be under the supervision and control of the InstitutionFoundation and the Investigator, and the InstitutionFoundation and Investigator shall without limitation be responsible for ensuring that the Staff act in accordance with the Applicable Laws and Regulations and, Biogen’s and its representatives’ reasonable instructions. (b)
Sample 1
Participating Staff. The Investigator declares to have undergone the necessary training and has the required experience and means for conducting the Trial. The Institution shall supervise that the Trial will be duly performed by the Investigator in accordance with this Agreement. The Institution shall not be able to replace the Investigator with another investigator without the prior written consent of Biogen. The Investigator shall provideBiogen and its representatives with information regarding the other staff participating in the Trial (the Investigator and the other staff collectively referred to as the “Staff”). For the avoidance of doubt, the Staff shall throughout the term of this Agreement be under the supervision and control of the Institution, and the Institution shall be responsible for ensuring that the Staff act in accordance with the Applicable Laws and Regulations and, Biogen’s and its representatives’ reasonable instructions. The Institution acknowledges and agrees that the Investigator enters into a separate agreement with Biogen and the CRO under which he/she will receive direct payment from the CRO for the services performed by the Investigator in connection with the Trial and by the other Staff members. The Investigator shall be responsible for the compensation of any Staff members that he/she decides to use in connection with the conduct of the Trial. The Institution assures that the performance of this separate agreement between Biogen and the Investigator will not constitute a violation of the Investigator’s duties nor a violation of the other Staff members’ duties toward Institution.
Sample 1
AutoNDA by SimpleDocs
Participating Staff. Institution agrees to allow Principal Investigator and other Study Personnel to conduct the Study at Institution. The Institution shall choose the Principal 3. Povinnosti zdravotnického zařízení (a) Dodržování právních norem. Zdravotnické zařízení prohlašuje, že splňuje všechny zákonné požadavky ohledně provádění klinického hodnocení, a že získalo nebo že získá veškerá nezbytná povolení. Zdravotnické zařízení zaručuje, že uzavření a plnění této smlouvy bude probíhat v souladu s platnými zákony a interními předpisy zdravotnického zařízení. Zdravotnické zařízení ručí za to, že plněním této smlouvy nedojde k porušení pracovních povinností hlavního zkoušejícího.
Sample 1

Related to Participating Staff

  • Participating Consumers All Participating Consumers as of the Effective Date will continue to be enrolled in the Program under the terms of this ESA unless they opt-out. Within one (1) day after the Effective Date, the Town shall provide to Competitive Supplier a list of Participating Consumers as of the Effective Date, as well as such Participating Consumers’ service and billing addresses, and any other information necessary for Competitive Supplier to commence All-Requirements Power Supply to such Participating Consumers as of the Service Commencement Date.

  • All Employees to be Members ‌ All employees of the Employer, as a condition of continuing employment, shall become and remain members in good standing of the Union, according to the Constitution and By-Laws of the Union. All future employees of the Employer shall, as a condition of continued employment, become and remain members in good standing in the Union from the date of hire.

  • Hospital-Association Committee (a) There shall be a Hospital-Union Committee comprised of representatives of the Hospital, one of whom shall be the Chief Nursing Officer or designate and of the Union, one of whom shall be the Bargaining Unit President or designate. The number of representatives is set out in the Appendix of Local Provisions and the membership of the Committee may be expanded by mutual agreement. (b) The Committee shall meet every two (2) months unless otherwise agreed and as required under Article 8.01 (a) (iv). The duties of chair and secretary shall alternate between the parties. Where possible, agenda items will be exchanged in writing at least five (5) calendar days prior to the meeting. A record shall be maintained of matters referred to the Committee and the recommended disposition, if any, unless agreed to the contrary. Copies of the record shall be provided to Committee members. (c) The purpose of the Committee includes: i) promoting and providing effective and meaningful communication of information and ideas, including but not limited to workload measurement tools and the promotion of best practices. Such communication may include discussion of nursing workload measurement and patient acuity systems. The Hospital will provide, upon request, information on workload measurement systems applicable to nursing currently used by the Hospital, and evaluations completed by the Hospital of such systems. ii) reviewing professional responsibility complaints with a view to identifying trends and sharing organizational successes and solutions, making joint recommendations on matters of concern including the quality and quantity of nursing care and discussing the development and implementation of quality initiatives; iii) making joint recommendations to the Chief Nursing Officer on matters of concern regarding recurring workload issues including the development of staffing guidelines, the use of agency nurses and use of overtime; iv) dealing with complaints referred to it in accordance with the provisions of Article 8, Professional Responsibility; v) discussing and reviewing matters relating to orientation and in- service programs; vi) promote the creation of full-time positions for nurses, and discuss the effect of such changes on the employment status of the nurses. This may include the impact, if any, on part-time and full-time, job sharing and retention and recruitment. (d) The Hospital agrees to pay for time spent during regular working hours for representatives of the Union attending at such meetings. (e) Where a Committee representative designated by the Union attends Committee meetings outside of her or his regularly scheduled hours, she or he will be paid for all time spent in attendance at such meetings at her or his regular straight time hourly rate of pay. Such payment shall be limited to two (2) Committee representatives per meeting.

  • Members (a) A Person shall be admitted as a Member and shall become bound by, and shall be deemed to have agreed to be bound by, the terms of this Agreement if such Person purchases or otherwise lawfully acquires any Share, and such Person shall become the Record Holder of such Share, in accordance with the provisions of this Agreement. A Member may be a Class A Member and or a Class B Member, and, in such case, shall have the rights and obligation accorded to the Class A Ordinary Shares with respect to such Class A Ordinary Shares and the rights and obligations accorded to the Class B Ordinary Shares with respect to such Class B Ordinary Shares. A Person may become a Record Holder without the consent or approval of any of the Members and without physical execution of this Agreement. A Person may not become a Member without acquiring a Share. (b) The name and mailing address of each Member or such Member’s representative shall be listed on the books and records of the Company maintained for such purpose by the Company or the Transfer Agent. (c) Except as otherwise provided in the Delaware Act, the debts, obligations and liabilities of the Company, whether arising in contract, tort or otherwise, shall be solely the debts, obligations and liabilities of the Company, and the Members shall not be obligated personally for any such debt, obligation or liability of the Company solely by reason of being a Member of the Company. (d) Except to the extent expressly provided in this Agreement: (i) no Member shall be entitled to the withdrawal or return of any Capital Contribution, except to the extent, if any, that distributions made pursuant to this Agreement or upon dissolution of the Company may be considered as such by law and then only to the extent provided for in this Agreement; (ii) no Member shall have priority over any other Member either as to the return of Capital Contributions or as to profits, losses or distributions; (iii) no interest shall be paid by the Company on Capital Contributions; and (iv) no Member, in its capacity as such, shall participate in the operation or management of the Company’s business, transact any business in the Company’s name or have the power to sign documents for or otherwise bind the Company by reason of being a Member. (e) Any Member shall be entitled to and may have business interests and engage in business activities in addition to those relating to the Company, including business interests and activities in direct competition with the Company. Neither the Company nor any of the other Members shall have any rights by virtue of this Agreement in any such business interests or activities of any Member.

  • Participating Employers As of the Effective Date, the following Participating Employer(s) are parties to the Plan:

  • Executive Management The PH-MCO must include in its Executive Management structure: • A full-time Administrator with authority over the entire operation of the PH-MCO. • A full-time HealthChoices Program Manager to oversee the operation of the Agreement, if different than the Administrator. • A full-time Medical Director who is a current Pennsylvania-licensed physician. The Medical Director must be actively involved in all major clinical program components of the PH-MCO and directly participates in the oversight of the SNU, QM Department and UM Department. The Medical Director and his/her staff/consultant physicians must devote sufficient time to the PH-MCO to provide timely medical decisions, including after-hours consultation, as needed. • A full-time Pharmacy Director who is a current Pennsylvania-licensed pharmacist. The Pharmacy Director oversees the outpatient drug management and serves on the PH-MCO P&T Committee. • A Dental Director who is a current Pennsylvania-licensed Doctor of Dental Medicine or Doctor of Dental Surgery. The Dental Director may be a consultant or employee but must be available at a minimum of 30 hours per week. The Dental Director must be actively involved in all program components related to dental services including, but not limited to, dental provider recruitment strategy, assessment of dental network adequacy, providing oversight and strategic direction in the quality of dental services provided, actively engaged in the development and implementation of quality initiatives, and monitor the performance of the dental benefit manger if dental benefits are subcontracted. A full-time Director of Quality Management who is a Pennsylvania- licensed RN, physician or physician's assistant or is a Certified Professional in Healthcare Quality by the National Association for Healthcare Quality Certified in Healthcare Quality and Management by the American Board of Quality Assurance and Utilization Review Providers. The Director of Quality Management must be located in Pennsylvania and have experience in quality management and quality improvement. Sufficient local staffing under this position must be in place to meet QM Requirements. The primary functions of the Director of Quality Management position are: • Evaluate individual and systemic quality of care • Integrate quality throughout the organization • Implement process improvement • Resolve, track, and trend quality of care complaints • Develop and maintain a credentialed Provider network • A full-time CFO to oversee the budget and accounting systems implemented by the PH-MCO. The CFO must ensure the timeliness and accuracy of all financial reports. The CFO shall devote sufficient time and resources to responsibilities under this Agreement. • A full-time Information Systems Coordinator, who is responsible for the oversight of all information systems issues with the Department. The Information Systems Coordinator must have a good working knowledge of the PH-MCO's entire program and operation, as well as the technical expertise to answer questions related to the operation of the information system. • These full time positions must be solely dedicated to the PA HealthChoices Program.

  • Participating Providers To find out if a Provider is a Participating Provider: • Check Our Provider directory, available at Your request; • Call the number on Your ID card; or • Visit our website at xxx.xxxxxx.xxx. The Provider directory will give You the following information about Our Participating Providers: • Name, address, and telephone number; • Specialty; • Board certification (if applicable); • Languages spoken; and • Whether the Participating Provider is accepting new patients.

  • Eligible Employees Regular and probationary, full time and less than full-time employees (on a pro rata basis) are eligible to participate in this program. Sec. 903 COURSES ELIGIBLE: The following criteria will be used in determining eligibility for reimbursement:

  • Benefits Committee As per LOA#10, a benefits committee comprised of the employee representatives and the employer representatives, including the Crown, shall convene upon request to address all matters that may arise in the operation of the OSSTF ELHT.

  • Senior Management If a Dispute occurs that the senior representatives of the Parties responsible for the transaction contemplated by this Agreement have been unable to settle or agree upon within a period of fifteen (15) calendar days after such Dispute arose, Seller shall nominate and commit one of its senior officers, and Buyer shall nominate and commit one of its senior officers, to meet at a mutually agreed time and place not later than thirty (30) calendar days after the Dispute has arisen to attempt to resolve same. If such senior management have been unable to resolve such Dispute within a period of fifteen (15) calendar days after such meeting, or if such meeting has not occurred within forty-five (45) calendar days following such Dispute arising, then either Party shall have the right, by written notice to the other, to resolve the Dispute through the relevant Independent Expert pursuant to Section 16.03.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!